Shortage of COVID-19 vaccine incites fears of forgery & hoarding
Shortage of COVID-19 vaccine incites fears of forgery and hoarding. The shortage may be linked to local officials or those who intend to travel hoarding the drug.
This current issue has raised questions regarding what is the cause of delay for the remaining 3.9 million doses of the Oxford AstraZeneca vaccines to be administered after one month from the delivery date?
How many states have finished their shares and the challenges for states that are yet to finish the shares they received?
When is the due date for the second dose for those who have received the first injection taking into consideration the standard medical duration between the first dose and second dose?
When will the next batch of vaccines arrive?
Reports have revealed that the arrival of the second dose of AstraZeneca COVID-19 vaccine is inevitable because the COVAX facility has informed Nigeria and other participating economies regarding delays of vaccines from Serum Institute of India and AstraZeneca.
COVAX works hand in hand with the Global Vaccine Alliance (Gavi), the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organisation (WHO). Its aim is to hasten the development and production of COVID-19 vaccines and to that, there is fair and equitable access for every country in the world.
According to a recent statement by the WHO, delays in getting supplies of SII-produced COVID-19 vaccine doses are primarily because of the increased demand for COVID-19 vaccines in India, for that reason, deliveries meant to be made in March will now take place in April.